Disclaimers on reports for the ASR changes?

<< Previous Message | Next Message >>
From:Nancy Shellhorn <nancy.shellhorn@zymed.com> (by way of histonet)
To:histonet <histonet@magicnet.net>
Reply-To:
Content-Type:text/plain; charset="us-ascii"

Dear Histonet Subscribers,

	I have been asked this question by several customers about the changes
on their reports after Nov. 23, when the new FDA ruling takes effect.
As I understand it you do not have to put a disclaimer in your report
unless you are dealing with a confirmatory diagnostic antibody such as
ER/PR or c-erbB-2 which I believe will be ASR antibodies? Please e-mail
all the users with your answers I believe everyone is anxious to hear
about the difference and what changes are going to occur in reporting. I
looked at the JCIM web site and it does not really address this issue.
Any thoughts on the matter would be greatly appreciated. Thank you to
all those in advance responding to this critical issue.

Sincerely,

Nancy Shellhorn
Zymed Laboratories, Inc.
458 Carlton Ct.
South San Francisco, CA  94080
1-800-874-4494 ext. 9002
nancy.shellhorn@zymed.com




<< Previous Message | Next Message >>